The Effect of Oral Oxytocin and Atosiban on Social Attention
ConditionHealhty
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexMale
Age18-35
SponsorUniversity of Electronic Science and Technology of China
About this trial
The main aim of the present study is to investigate whether orally (lingual spray) administered oxytocin influences human social attention and behaviors via oxytocin receptors and whether its effects are dose- and task-dependent.
Eligibility criteria
Qualifiers
Healthy male subjects without past or current psychiatric or neurological disorders
Disqualifiers
History of or current neurological/psychiatric disorders;
Use of psychotropic medications (including nicotine)
Visual impairments
Trial design
Treatments tested in this trial
- Oxytocin lower dose (24IU)
- Oxytocin higher dose (48IU)
- Atosiban
- Placebo
Treatment groups
250 Participants
are divided into 5 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov